MedPath

High Resolution Imaging for Early and Better Detection of Bladder Cancer

Completed
Conditions
Bladder Cancer
Interventions
Device: Standard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution Microendoscope
Registration Number
NCT02340650
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

The goal of this study is to develop, optimize, and validate a High Resolution Imaging System in the bladder that displays images in real-time, providing automated diagnostic criteria for bladder cancer screening. High resolution images of normal bladder tissue and suspicious bladder lesions will be collected from patients who present to the study site for clinical evaluation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • Diagnosed with clinically suspicious bladder lesion or clinical finding; or who are undergoing cystoscopy as part of their routine clinical care.
  • Must be willing and able to participate and provide written informed consent
  • Women of childbearing age who have the possibility of being pregnant must have a negative pregnancy test prior to participation
Exclusion Criteria
  • Patient with sufficient evidence of cognitive impairment that limits the subject's ability to understand the protocol, provide informed consent, or to comply with the protocol procedures.
  • Women with the possibility of having the pregnancy.
  • Patients having acute infection.
  • Person with Lidocaine sensitivity.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Bladder Cancer PatientsStandard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution MicroendoscopeHigh resolution images of normal bladder tissue and suspicious bladder lesions will be collected from patients who present to the study site for clinical evaluation.
Primary Outcome Measures
NameTimeMethod
Specificity of Bladder Cancer Detection Imagingbaseline (at the time of imaging)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Lyndon B. Johnson General Hospital

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath